24.2
Abbott Laboratories
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
25.2
FY23:
22.7
FY24:
23.7
FY25:
26.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
51.0
FY22:
49.2
FY23:
50.5
FY24:
57.8
FY25:
60.7
Total assets
Change from FY21 to FY25
billions USD
FY21:
75.2
FY22:
74.4
FY23:
73.2
FY24:
81.4
FY25:
86.7
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
13.1
FY22:
15.5
FY23:
13.8
FY24:
14.2
FY25:
16.5
(negative)
Change from FY21 to FY25
billions USD
FY21:
26.1
FY22:
22.0
FY23:
20.5
FY24:
19.4
FY25:
17.4
(positive)
Change from FY21 to FY25
billions USD
FY21:
35.8
FY22:
36.7
FY23:
38.6
FY24:
47.7
FY25:
52.1
All amounts in billions USD